Skip to content

Clinical evaluation of Pachai karpoora Mathirai for Acute Bronchitis.

A Clinical evaluation of Pachaikarpoora Mathirai(a siddha drug) in The Treatment of Kaba suram(acute bronchitis) in children.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008457
Enrollment
40
Registered
2017-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with the symptoms of Fever difficulty to breathing dry or productive cough constipation running nose malaise

Interventions

Intervention1: PACCHAI KARPPORA MATHIRAI: PACCHAI KARPOORA MATHIRAI is a polyherbal formulation 1 tablet od 8 to12 years oral route 1 day Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with symptomps of Temperature 99-101degree fahrenheit difficulty in breathing dry or productive cough constipation running nose malaise willing to give specimen of blood for investigation when required

Exclusion criteria

Exclusion criteria: Temperature above 101 degree fahrenheit fever above 3 days H/O Convulsion H/O Typhoid H/O Malaria H/O Jaundice H/O Active primary complex H/O Pneumonia H/O Rheumatic fever H/O UTI Patient not willing to give consent for study

Design outcomes

Primary

MeasureTime frame
Results and observation during the study inclusive of clinical improvementTimepoint: 1 day

Secondary

MeasureTime frame
clinical efficacy of the trail drug and its side effects if anyTimepoint: The experimental drug may have good efficacy and safety in clinical study

Countries

India

Contacts

Public ContactDr M Meenakshisundaram

National institute of siddha

mmssiddha@rediffmail.com9940266442

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026